Concepedia
Statistics
Publications
6
Citations
429
H-Index
Active since
2000
Affiliations
West Michigan Cancer Center(Current)
Harvard University
Emory University
Dayton Clinical Oncology Program
Dana-Farber Cancer Institute
Raymond S. Lord is an author at West Michigan Cancer Center specializing in oncology, medicine, and hematology.
Publications per year
2000–2016
Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
J. Greg Slatter, Larry J. Schaaf, James P. Sams et al. · Drug Metabolism and Disposition · 2000 · 299 citations
Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15
Preliminary Report of a Multicenter Prospective Phase II Study of DA-EPOCH-R in MYC-Rearranged Aggressive B-Cell Lymphoma
Kieron Dunleavy, Michelle A. Fanale, Ann S. LaCasce et al. · Blood · 2014 · 55 citations
Medicine, Hematology, Oncology +9
Immune hemolytic anemia caused by sensitivity to a metabolite of etodolac, a nonsteroidal anti‐inflammatory drug
Patrícia da Silva Cunha, Raymond S. Lord, Susan T. Johnson et al. · Transfusion · 2000 · 28 citations
Medicine, Hematology, Pharmacology +11
Stability of decisional role preference over the course of cancer therapy
Julie B. Mallinger, Cleveland G. Shields, Jennifer J. Griggs et al. · Psycho-Oncology · 2005 · 27 citations
Medicine, Oncology, Medical Oncology +5
Single-Agent Topotecan as First-Line Chemotherapy in Women with Metastatic Breast Cancer: Final Results of Eastern Cooperative Oncology Group Trial E8193
Antonio C. Wolff, Anne O’Neill, James A. Stewart et al. · Clinical Breast Cancer · 2005 · 10 citations
Medicine, Oncology, Pharmacology +14
1–5 of 6